Hematopoiesis, the process by which all blood cells are formed, is a tightly regulated process that is disrupted in a number of blood diseases, including leukemias. The main interest of our laboratory is to define the mechanisms that regulate normal and leukemic hematopoiesis. Current projects include the following:
Characterization of leukemic stem cells
There is accumulating evidence suggesting that most leukemia is initiated by a subpopulation of leukemic cells, referred to as leukemic stem cells. Our laboratory is interested in defining the genetic and epigenetic alterations that contribute to transformation in this cell population.
Characterization of the role of microRNAs in leukemia
There is emerging data suggesting that non-coding RNAs, in particular microRNAs (miRNAs), play an important role in the pathogenesis of human cancer. In our laboratory, we are using next generation sequencing technologies to identify and validate dysregulated and mutated miRNAs that contribute to transformation in leukemia.
Characterization of the pathogenesis of congenital neutropenia syndromes
These syndromes are characterized by neutropenia at birth and are associated with a marked propensity to develop leukemia. Studies to define the molecular mechanisms of disease pathogenesis and leukemogenesis are underway.
Regulation of hematopoietic stem cells by the bone marrow microenvironment (stem cell niche)
Studies are underway to characterize how normal (and leukemic) stem cells interact with stromal cells in the bone marrow to regulate their function. In particular, we are studying how G-CSF alters the bone marrow microenvironment and leads to the mobilization of stem cells from the bone marrow to blood (see figure).
|
Regulation of stem cell niches in the bone marrow by G-CSF. Treatment of G-CSF leads to a marked suppression of osteoblasts in the bone marrow, leading to the mobilization of stem cells into the blood. In contrast, the vascular niche appears to be unaffected. |
| 1981 | BS, University of Wisconsin-Milwaukee, Milwaukee, WI |
| 1985 | MD, University of Wisconsin-Madison, Madison, WI |
| 1984 | Medical Research, NCI summer training award, NIH, Baltimore, MD |
| 1985-1986 | Intern in Medicine, Barnes Hospital, St. Louis, MO |
| 1986-1988 | Assistant Resident in Medicine, Barnes Hospital, St. Louis, MO |
| 1988-1992 | Hematology-Oncology Fellow, Washington University Medical Center, St. Louis, MO |
| 1993-1996 | Instructor, Department of Medicine, Washington University Medical School, St. Louis, MO |
| 1996-2003 | Assistant Professor, Departments of Medicine and Pathology & Immunology, Washington University Medical School, St. Louis, MO |
| 2003-present | Associate Professor, Departments of Medicine and Pathology & Immunology, Washington University Medical School, St. Louis, MO |
| Program leader, Hematopoietic Development and Malignancy Program, Siteman Cancer Center | |
| Member, Basic Science Leadership Committee, Siteman Cancer Center | |
| Markey Pathway Admissions and Steering Committee, Washington University, St. Louis, MO | |
| Summer Scholars Program in Biology and Biomedical Research Admissions Committee, Washington University, St. Louis, MO |
| 2002 | Editorial Board, Experimental Hematology |
| 2002 | Editorial Board, Blood |
| Alpha Omega Alpha | |
| American Society of Hematology | |
| American Society of Clinical Investigation | |
| International Society for Experimental Hematology |
| 1989 | American Board of Internal Medicines |
| 1990 | American Board of Hematology |
| 1981 | Kurt H. Vanselow Undergraduate Research Scholarship; University of Wisconsin-Milwaukee, Milwaukee, WI |
| 1981 | The American Institute of Chemists' Student Award; University of Wisconsin-Milwaukee, Milwaukee, WI |
| 1981 | Phi Beta Kappa; University of Wisconsin-Milwauikee, Milwuakee, WI |
| 1981-1984 | Outstanding Achievement Award by Promotion's Committee; University of Wisconsin-Madison Medical School, Madison, WI |
| 1982 | Academic Excellence Award (top 2% of class); University of Wisconsin-Madison Medical School, Madison, WI |
| 1984 | Alpha Omega Alpha; University of Wisconsin-Madison Medical School, Madison, WI |
| 1984 | NCI Summer Training Award; National Institutes of Health, Bethesda, MD |
| 1993 | McDonnell Scholar in Molecular Oncology; Washington University Medical Center, St. Louis, MO |
| 1998 | 28th Mallinckrodt Scholar, Edward Mallinckrodt, Jr. Foundation |
| 2000 | Election to American Society of Clinical Investigation |
| 2005 | Medical Advisory Board of the Severe Congenital Neutropenia International Registry |